CervoMed (NASDAQ:CRVO) Given New $21.00 Price Target at Canaccord Genuity Group
CervoMed (NASDAQ:CRVO – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group from $12.00 to $21.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 124.12% from the company’s […]
CervoMed (NASDAQ:CRVO – Get Free Report) had its target price lifted by equities research analysts at Canaccord Genuity Group from $12.00 to $21.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective would indicate a potential upside of 124.12% from the company’s […]
